Theravance Biopharma, Inc.·4

Mar 4, 6:09 PM ET

Miller Aine 4

4 · Theravance Biopharma, Inc. · Filed Mar 4, 2025

Insider Transaction Report

Form 4
Period: 2025-02-28
Miller Aine
SVP, DEV & HEAD OF IRE OFFICE
Transactions
  • Award

    Ordinary Shares

    2025-02-28+75,000214,261 total

Documents

1 file
  • 4
    form4-03042025_110312.xmlPrimary